XAIR - Earnings call 3 2024 | Beyond Air, Inc.

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Good afternoon, and welcome, everyone, to the Beyond Air financial results call for the fiscal quarter ended December 31, 2023. [Operator Instructions] And now I'd like to turn the call over to Corey Davis, LifeSci Advisors. Please go ahead.

Corey Davis

Thank you, operator. Good afternoon, everyone, and thank you for joining us. closed, quarter a financial XXXX market the release results. the third fiscal operational after we press issued announcing Today, highlights and our A be News press this Events website, on and copy the www.beyondair.net release section. under of found can .

Act harbor remind Securities forward-looking I making XXXX. will of statements of various about for to and Litigation and plans safe that future we purposes Before we expectations, like provisions prospects, everyone Private begin, remarks would Reform under be the comments which the constitute

Beyond cause differ which are or identify encourage uncertainties actual statements. those Air company's forward-looking to factors cause without subject the to the described may events Exchange statements We specific and the including, the cautions recent limitation, Form that XX-Q, actual these filings risks Commission, and that results Securities with everyone indicated. materially most materially forward-looking could to in review to company's from the differ results those from XX-K Form and

is call contains time-sensitive will beyondair.net. only of XXXX. live call conference conference broadcast, on of be this date Furthermore, that the February this is website the rebroadcast audio being as information accurate our Additionally, the for content available and of XX, recorded

or revise events of any this Beyond no obligation call. after the Air undertakes to statements reflect circumstances to update or date

Go Chief Lisi. Joining Officer. Steve With are the Chief turn Steve. Steve Larson, over call and me to Douglas Financial on Executive that, today Lisi, Chairman Officer; and it I'll ahead,

Steven Lisi

last in revenue step us than increase a the quarter with Today, Thanks, versus right greater good Corey, we announced everyone and in quarter. a strong to today. afternoon joining XX% this direction

as fiscal several our it the that million absolute to September give to takes XXXX in guidance does in change XXX% the reflect such fiscal a in received compared factors in million. upgrade that XQ from hitting $XX confidence important with It's for XQ. FDA While this us this grew manufacturing by software is shipments note than a growth result number fiscal systems. $XX shipped more of in yet terms, revenue not upgraded Filters year in to there small are time

start with February on was hospital the updated new X. first Our system

As this upgraded evaluations as compared at Academy November. XX and started in in next is bit Care new financial that completed, revenue the see The rollout since months. surged base important levels the our was we the March as It just scheduled impact customer months a have completed maintain the has has for be we for new have muted the expect begun, understand quarter will quarter. the many existing balance a evaluations adding between system the with customers. displayed the of we the machines conference, product as in to in upgrading we will of June several our in definitively American Since previous early increase demand or Respiratory of to

margin. announce multiyear upgraded to the by had single a with requests X to we X have than year Prior wide engagements such contracts. am that today pleased we I more multiyear now requests system,

accuracy. removes improves software system all our compatibility upgrading reduces improves alarms and reference, For sensor issues, noise,

We their hospital. have with told that head-to-head a we every comparison any competitor hospital welcome in

same system very willing instances multiple competitor and in a where we sit use to to us few through had surprisingly, not cases a their cycle the at our system. However, have was with hospital room with

the healthcare provider to the since [indiscernible] reach stages, with We're driven expand innovative early in been its we from company. this Vizient, securing network. the improvement also nation's contract award excited have our to progress largest still our performance by pleased technology While made through customer opportunity

field they our will the group market, on of review over cardiac this oxide positive we the to out year. our last continue as supplement surgery capitalize expansion To include PMA more course One FDA. team make opportunities LungFit for the anticipate purchasing a nitric substantive is the to label by adding under U.S. growth point next PH the the also trajectory, organization platforms We to was on evolve. accepted based growth and on of build to

Our clinical is commended together for team and regulatory a submission. to strong putting be

While XXXX. FDA growth we is no there of decision on would revenue an is for end complete firm their received, after we few the date months. review, anticipate to approval a impact before calendar expect a Once

CE we in XXXX. still year first States, the outside of of Looking expect receive calendar half Mark the United to

our payment mentioned several will Pacific has As previously, Asia with this mark our system, an LungFit to a we signed countries have in [indiscernible] Japan. addition CE in for region, in excluding commercialize partner, which agreement milestone us in from trigger receiving PH the Europe doors to up opening Healthcare,

our on to pipeline. Moving

no given preclinical reported is in [indiscernible] there data an like safe dose-limiting the that During per cleared of parts the Uno XX,XXX Phase of dose the refractory shown relapsed an immune Uno studies. cohort advanced response for much by at with or announced or first has solid we that the the quarter, committee cancer confidence or saw November study metric that is should toxicities. XX,XXX conference, I ultra-high This cutaneous human million metastatic concentration [indiscernible] its subcutaneous is there and there SITC oxide review means beyond in in Uno be use. tumors evaluating oxide single-dose primary And unresectable

expansion. portion XX,XXX reminder, X cohorts, XX,XXX concentration expansion Uno of objective and dose dose a secondary oxide safety therapy. escalation Uno a primary trial biomarker part a study the dose The consist Uno parts and tolerability of recommended assessment is the dose of response immune and that efficacy will XXX,XXX million. parts, in possibly with conducted per of with the of nitric is XX,XXX, parts determined to X a to this of The dose below once is assess As escalation dose million begin first-in-human or objective by will the being study per

the data calendar all Phase the the beyond anticipate suffering year strong study in of Ia potential then completing Ib which the that the back on the website and year, calendar study Phase One to initiating a from this we and solid anti-PD-X educated half last preclinical data half will this those of combination in tumors. with of transformational presenting note is include cancer visit in encourage better date therapy therapy, shown for therapy to to you get I the given setting. combination first

Our pneumonia underway. VCaP viral community-acquired studies or

[indiscernible] this reminder, days. intermittently a to XXX placebo-controlled nitric treat will oxide up hospitalized with As X randomized, pilot study double-blind, patients for million

to following Due this patterns is activity, running and months. seasonal winter study of pneumonia a fall through the seasonal viral

expect top line when decided of study announce year data this we updates have conduct Thus, the XXXX, middle over by As a result, to we interim calendar data X with seasons. is in to timing appropriate. need for a significant season. 'XX This viral times pneumonia will pivotal the study given we not medical in. unmet Obviously, a 'XX, live change the the

our autism to program. Turning

track that the in Please data pleased exciting are data. early on XXXX. partnership to continued program preclinical Heavy Jerusalem, being recall this which University for is the stage human We development program of with produce in remains that conducted

the oxide As disorder offers reminder, molecular nitric autism demonstrated a the several reduces and updates this synthase, the the shown by biomarkers with as to nitric autism have spectrum be stress tremendous far genetic and nitrastative oxide that associated progress synaptic behavioral To and of was in throughout reverses year. brain production We providing data associated phenotypes. neuronal models inhibiting forward thus mouse of different potential autism. we behaviors clear, in program a look reversal believe reducing

it turn Doug? will Doug I CFO, Now, our over to Larson.

Douglas Larson

Steve, and Thanks, good afternoon, everyone.

the for follows: results ended compared XX, December quarter Revenue the the fiscal quarter as previous for XXXX, are ended December fiscal million X Our $X.X for million the XX, as $X.X XXXX. and quarter for quarter was financial fiscal with

why gross X remains margin seeing While there operating overall are individual positive contracts, our on we our margins negative. are reasons

incurred complete upgrade of there software LungFit costs will for devices. quarters related the upgrade of be as all our next we First, costs of devices. to the we Note the X similar the

because hundred prebuilt devices Second, that currently upgraded. are being we several

We have revenue. of depreciation generating not are that devices currently

stage will physical we but Third, are our warehousing in this we of suboptimal this early consistent dissipate. effect infrastructure, growth, as grow with

comps teams. development to due incremental in great associated due location the cancer, by mostly our key. autism. was this was mainly for fiscal is the with we XXXX. December million fiscal and to upgraded million for ended the Air's partner to from quarter being right million offset the exclusively high-quality start up supply R&D million ramp engage of quarter is of development costs hospitals to with favorable continued was expenses in almost compared committed XX, Our number the systems $X and $X.X in $X.X Beyond The salaries having $X.X million and NTM were Of $X.X right with chain loaded beyond Investment a spend, pipeline, BCAP the study. but in Research remaining to our the

increase increase $X.X with million for There's the $X.X again SG&A December a showed in the of XXXX. and for income the stock-based moving gains a mainly securities. million an majority million expense ended million, XXXX. gain $X.X fiscal quarter were salaries expenses expense Other $X.X compensation quarter for and $X.X a fiscal fiscal compensation. compared million $X.X for due with quarter million was ended to noncash the being XX, $X.X the parts biggest lot with a compared our from in interest are XX, million loss quarter marketable by partially fiscal the offset movers being of this December but increase The quarter,

net XXXX, compared on loss basis, to fiscal Air, the $XX.X a shareholders net XX, million quarter $XX.X quarter or Beyond of of recorded fiscal $X.XX XX, or million for For the million of share of with a the a $X.XX the ended loss company XXXX. December a $XX.X share ended which GAAP was attributable per December Inc.

ended and in device, to payments cash in of cash in was alluded burn study, development last XXXX, towards higher continued advances VCAP program. Net our our our in with autism Gen million. quarter call, $XX.X this XX, used December human in our cancer beyond required X trials quarter a We the

the $X.X We our planned on also to million ATM the compensate partially in quarter burn. cash raised

a XX, XXXX, to deposit December I'll also marketable And And the million call that, $X.X contract securities hand of we on equivalents had million. $XX.X and held cash, reminder, back have manufacturer. with our Steve. the as As company of by cash

Steven Lisi

Thanks, Doug.

will any now We . may take have. you questions

Operator

first the Our from line comes Piper Bednar question Sandler. Instructions] Jason [Operator of with

Jason Bednar

I step million of some steps more all front, good. as of context about forward If maybe developments, back million the guidance about and year, your some That's $XX start clearly in revenue next future clearly, where there. When recent for mentioned $XX well. the on we're confidence on you some think you're ways I at to the signaling could contracting just contracting

and I and consider also So a new January the $XX I I jumping Can least a year back you've year. point to at million think, into that in million move commercial exit to of tends order good be, when period early the 'XX. range, a this that needing to about up happening $XX at or here discussions guess, off signals contracting seen in good you talk calendar lot here maybe to

Steven Lisi

Jason. Thanks, so. with some question. long the increase prepared very remarks, That's want we our asking very mentioned the We're in especially the good. the in of us, which the requests system. our do happy prepared for to confidence in said seeing, us. Appreciate as a contracts software. remarks, in, locking We're massive system, us us longer-term term Like in contract seeing upgraded for I for for is with evaluating with Sure. to customers They earlier

are next to X scheduling we the that. So more weeks, beyond consistently and X we're scheduled over

customers new existing for next of is our interest entertaining there. and months. in we as now well the are certainly So the as to customers couple Again, parallel attending

base system customer the with how very us. to us prior and to our They've helped important update. been they've understand the to existing system is software working Our optimize

them customers we're to of And care some going in new that. appreciate well. as we as take bring So well as

as of once exciting and And just XXX% customers, they're very -- that team. new focus Jan a taken efforts this for us can will our start a So care X on be to is hospitals. not we for

up, July X. other of year. where certainly the Jan of that's of mentioned the lots points the But year there Jan a X busy are with along contracts being time You biggest probably X, beginning there's in end at starting the

starting going it's and a a making We hospitals starts. hospitals lot of are every taken us that first our available Their of. There on. supply customers their month, there's having start the mentioned mid-month, Feb earlier, we of So so have on sure the just matter -- like are existing just starting a I on care X.

very We're coming. months. team able X adding what's see be we to coming So in We'll handle about the to be it. to the excited what's to people next X

need, but go ask. you'd else say. are ahead don't metrics the know So need you just that's all more if can mean, I metrics, want I I and you what some

Jason Bednar

qualitative and to just for to it more backfill this reference No, personnel more can anecdotal around use like get segue Maybe that's are things there any sure. next sense, and Dunkin's the in trying sounds how get quickly the to direction give moving a I'm I'll right to more maybe you looking helpful. to just color -- departure, your spot. question super is you're just

You're just and a there's seamless want commercially. obviously I transition at call critical point make it, here. a inflection sure quick to

Steven Lisi

Yes.

the transition pretty that I when someone up. strong internally. think new have a I be that But here role don't team we'll will in seamless. know we starting have

need right hand. the going for because I But job the the I to and as we're things certainly bringing for at these we So as done on task to company not we And But wrong a focused we person, opportunities at is our together think obviously, we're the wish add Duncan quickly forward. us. someone we're wait people in person have team the working to great grow we a right as bring need And way. attitude. now. best right the he's right come the

whether have I that you XX I role. for wait we right want way, or I in can't can in certainly tell that what that that days, the the right XXX come don't to days, think with I person But So XX person know. days be right we now, . in place, our

Jason Bednar

It Doug. margin is then parts. help some days they're way -- one there I have Okay. it's quarters. -- be strip here they X one, I moving right. on gross were what to next like know been? Makes here, the All trying for sense a just would sense. early a but to quarter second the or your and out quarter but quantify if sorry, elevated the those third get some of fiscal costs of onetime super appreciate And last -- going sounds the to there in

have Just get an trying model in this goods would would appropriately, maybe like adjusted have adjusted a like for or looked the as looked sense you what quarter. we to margin of out cost sold gross

Douglas Larson

and pieces. quarter. Yes. talking the I on. that in and the But a am deployed somewhere between hesitant break little machines the the were Thanks, to aren't Jason. refits out that between we We're upgrading devices on for software depreciation $XXX,XXX $XXX,XXX the

we of quarter those -- devices, gives as going kind again. And So you that -- more I sales think are hope the normal those I of all numbers just upgrading that we that to up cost disappear. as next And will the of idea . our of depreciation then recur sales. an obviously, and then a part -- pick done that are revenue, get becomes

Operator

next with question Our the from Sulewski of comes Leszek Truist. line

Leszek Sulewski

second a you X engagements I among -- the your around the part in and the what if sizing new Steve, be engaging the give decisions is you the the new environment just pricing hospital little mentioned? on hospital that? threw guess, on of that, that to driving on then rate the are you up the can would could, setting, And how bit just groups of the you've conversion color, expectations environment more

Steven Lisi

there. Those Let we with What inked. are have that. by you those on are me already deals. Those rate start multiyear contracts. Those just do on So are that? conversion mean

Leszek Sulewski

more that, sizing color little possible? a of give you if Can on that's the

Steven Lisi

-- them below and market X of consider double of them I average. is would X say average, market you that what probably slightly probably are

patients do consider good be hospital. volume. sized pretty hospital But that is the the detail what mean want that good-sized machines day. to contracts. patients of is one are on I volume, too but a would lot bit good-sized little be, X the So over every we've are mean, there's a doing big much good ones I It's volume. to on I got even hospitals. in below single other a I a it, XX average hospital. of lot -- pretty give these they're would really They're these

So that hope I helps.

There's back So it. question. about prior doubt plays back a to It's me price certainly role. no let go your

in decision we And this fact. can, much only mean, price certainly the pretty I not think that's -- the market. that's we think we thing plays but range the that plays this that to is I've true into for a off hospital, the role. the that hospital when not get to I the best they a it I can't within but said naive that that wants too any think that situation, entered pricing far environment we I be what expected before, anticipated. It's the from

volume than the Some hospitals based others get pricing factors, better factor. will probably biggest certain on being

think price, want don't only a the impression to give for is I bottom this to don't not in it's that market I true. factor, just the the it's this But and race you

I pricing think a healthy it's environment.

Leszek Sulewski

Got it. Very helpful.

study, can you Or little filter was X give commentary you then inventory And utilization? Can into Just more more bit on translate onefold separately, a your little seasons? is color On shipments. that could. the seasonal on increase VCaP how just the that, extended a on you a this if give stocking? this into

Steven Lisi

it's just about growth. what nothing this for depends but of that no I next need it need -- are. stocking not Yes, mean of is hospitals year needs, days, works. how mean supply really on the individual XX for different up hospital have XX, next they This XX, don't it they stuff. seasonal stock hospitals, the the the -- inventory mean -- a will that's I these stocking to up. no stuff it. they're are there's seasonality numbers no, just There's There's here the normally, what numbers this I ordering no

true a just it's growth. So

look, the I study. mean, VCAP safety this on study, So is

need to it X efficacy, necessarily be doing season. safety in season, needs X be to you're doesn't in If

last our was a It our for won't we and the that get to approval of on all season. the the my in for off date running study, to the tight change pivotal little Given time quarter late we pressure team, take June got up sites year.

extend So that decision we -- would Thanksgiving a around X over seasons. we made this

out. And was decided just we'll as something always on up all it case, couple try as a our was centers, to then, get couldn't just that and the ourselves than sites in we pocket, needed. focus It running quickly we in to and back spread but core spread of rather

trying time gave didn't, what it's think go, We really a we the make you don't best into the season, I frame. I that, that's decision got in and it shot. think short we on to way given the before X done get to to had but it we swing did. the season of a

So pivotal push at always I study a long think our doesn't Again, don't considered internally. we it problem all. something as it's out was it as start,

it's think right I the the to thing actually given do situation.

Leszek Sulewski

of it. the pipeline the a around quantify risks whether level, from That's strategy and Maybe -- time thoughts further could order, Got helpful. high-level that or kind the -- process kind could any be pipeline? of pushed involved, financial pecking around you anything strategy high back there's color your it's if

Steven Lisi

a in cost. then, humans high maybe some mean, in really kick I relatively to Ib start the mean showing ones program, for I for getting what that But to and autism is are cost working expensive. I getting on a now. I I not or obviously. overly that's lot it's will are think cancer, Again, 'XX we're first we programs, mean, IIa I the autism until that think when pretty X once It's the inexpensive go mean that's one into in. doing. compared not much right it I it's us that and Phase when preclinical. to Phase not VCaP, other we're costing everybody data, we mean

our is next NTM program up.

That's before some meeting design. get forward. has pivotal we'll with year, trial a that them work COPD corporate our end calendar ideas is year a moving from evident that obviously That's Hopefully, think be trial and the them been not of goal. will presentation. on in I this FDA be our design. to with

the at kind hold. So the there bronchiolitis that's hold just sitting also one on moment. on that's of

couple last I think that's been of clear years. for the

I they it's are priorities our So in very what where think pipeline clear and are. the

I I don't I your question, the So if rank don't know but -- I there's if know I there. gave think answered

Leszek Sulewski

Thank Steve, helpful. you that's No, for appreciate that it.

Operator

from Laidlaw comes question next I-Eh the with & of Jen Company. line Our

Yale Jen

hospital multi-contract guys Maybe start on reported using you or that actually already the using what the total been to X the has device? be the [indiscernible]. Have of including one the used number

Steven Lisi

Yes. Yes.

give out We to haven't hospitals many said out hospitals who the there. they many public we're general to how want they any in are, are where information or We how are. about don't

to that. on But. going not comment we're So

Yale Jen

updates, compared Okay. in That's of little a good. a to fine. specific of the terms the the -- just -- the earlier bit make update more in aspect general one. That's previous Maybe significant software color of makes the terms difference which

Steven Lisi

Yes.

background. early So just system froze of little tiny we to our XXXX. design the in Remember,

pandemic. then had So we this global lovely

took it time extended the while to a to approval. So to time extended submission,

makes So years there's our changes us it is changes of no to the things for the that right a rest up having of X.X difficult system in away. catch of where world lot

So software compatibility there this all accuracy moment all time. our would are and for to the for us I gave gave and in think there the we're with with systems used. us out are say very at us all sensors our important. update that out essentially, this monitoring I with It delivery. ventilators that anything be important systems, are That's incompatible the don't with that optimal compatible

compressors, bit software noise. is the so noise think reduce from hospitals that, to a our nicer big little to and the don't but a for certainly, was have There's deal, able that the we're some alarms. to that of big, on improve able of I

So that's it. really

frustrating of it with really are this expected. accuracy it. but things X lot and That's driver say a a November did we're are early mean a would like did a the us. did, we I said lot X happy probably lot now, from I why American think long little and getting And biggest earlier, Everybody more things of and -- as it. in interest feedback compatibility as and it the as for Academy I the that for I it's Respiratory is Care. displayed sensor Since very and the the the it that we looks those hospitals. pleased more this is here at took

Yale Jen

terms a recently Okay. therapeutics impact indicated. the just on in at company they is a Maybe NTM, efficacy in on for study Do last on any that Or [indiscernible] a guess there my this of question comments I indication the here see Phase any you [indiscernible] pause point II/III similar this based the as is of your that? development in indication?

Steven Lisi

sorry, mentioning? you didn't I'm it what the that hear was company were I name.

Yale Jen

It's called [indiscernible] in [indiscernible]. therapeutic Yes.

Steven Lisi

correct? Yes, I -- is antibiotic, lease yes. they're using believe that an that

Yale Jen

efficacy, paused Right. reason study. they that support the And the in hinted release their at that have and Phase they that, basically, they least press suggest they II/III that's

Steven Lisi

Look, a big anything is that's patients positive win. for these

I'm patients, So that be may they to happy very hear that's able to help fantastic.

more it's these few. options They patients. for very have So

to think thing. that think path could even I through FDA, we see. good the make have And easier I it it's perhaps a So

and what our happens wait to being on of studies done right therapy. now, antibiotic have with top We see are them. But

know with I in would going So we're just be be used near together term. doing studies the I any to we think antibiotics, monotherapy don't if

the certainly great at efficacy in point, with any this oxide of great and antibiotics seen patients. tolerability as us, antibiotics we've studies. our for -- the So helps with Nitric for is enhances success

Yale Jen

their study. on think they I have study efficacy they their enough paused because don't

Steven Lisi

reasons. I it for data failure, the was had -- so stopped a was It negative

Yale Jen

stop. the It's negative For not reasons. early

Steven Lisi

need bad options. patients Okay. again, too these that's Well,

be hoping things that work we'll them. So would for

think do our that. go strategy monotherapy, that background But But So at all. never But early to it's just patients case, speak it with great. our therapy. change time, used at little to this as way doesn't going mean, would point any upfront [indiscernible] a you strategy. doesn't I I be we're any antibiotic If we'll existing we know. in FDA, change with there's can be a in this

We unique a action treating disease. certainly for lung mechanism NTM are of

So way look change it's not at to the things. we going

very in we we're mean excited strong data I so it. for pretty data the had itself. study speaks Our about last we did,

Yale Jen

progress Okay. Great. moment. Congrats at the I it. appreciate on this

Steven Lisi

it. . Appreciate Jen. Thanks,

Operator

Our next question with of BTIG. Marie the Thibault from comes line

Unknown Analyst

can as to on get This Marie. we for the here. mark Maybe is Sam CE I [indiscernible] closer start on approval

Just Europe guidance highlight target thoughts the how time. to us, Any in markets for for contribution? in APAC. that on you'd anything included and international about And any at 'XX ramp both the think revenue this fiscal

Steven Lisi

don't think still time the that things I then things I give anything have we've Sam, then get deal -- we we're a CE ramp CE I to have Union takes we'll to mean going European up. from and and 'XX. will in Australia ink a I you approval Australia, can't in we'll ramp It Zealand, to the got Yes. think TGA in that take, sure, the the but have Europe. New mark, to estimate, lag that's days. up. or be XX then I mean rough mark,

in 'XX. from 'XX, effect any there's it there, minimal be fiscal will if So

be wouldn't very I would think it impactful. So

more for 'XX, think fiscal is both I fronts. us a impact that this on 'XX . of

Unknown Analyst

adding to half think of on about expenses of to any 'XX. obviously, or and back maybe to my just here guess quantify I Okay. follow-up that to team. some That's around incremental the operating contribution the year And just ramp think about. way I helpful use this here can field and the fiscal in comments

Steven Lisi

we're Yes. I and our mean now for we interest see in doing -- our our we already budget interest forecast, for being need bit this. based budget, We in adding right? this, people is We the already upon what have in our for added -- little up bulk prepared in system. the to way, right? be a our coming So team need to we we what

quarter, behind are where we change are X people we're or X going Whether X it's or X out X X anything. for in I going not in to we or next smooth budget. quarters. It's people going X be the all So to it's mean over to quarters. our a to ahead probably certain in

guidance our increase expenses. going quarter each in starts bit part It's This our burn, bring is our might all we're Just in it's going what plan. demand to mean all when. a expect on. different terms people the in is of happen nothing I for there. we little we It's to this the see budget. be coming, of exactly who it's new. not to when But It's

Operator

from of Matt comes Kaplan the Thalmann. question next Our line with Ladenburg

Matthew Kaplan

Just you're with conversations you -- that -- in of for million the guess, more that. bit terms XX in you to . your what see, XXXX. us terms of different And your color in achieve of I these having a XX million some you're little guidance to wanted of confident to give on conversions why if [indiscernible] need can with

Steven Lisi

Matt. Thanks,

them X,XXX don't all. these because discussions to lot you in do need of portion here, a the to of coming couple see existing look, but having. of There's about we keeping a winning the customers, be them we're resignings that resigning no we expect are we good is up next So months. What win way expect our

And where our out our on by already build because some August be numbers July, bring on more where to hospitals. will we'll that have care think taken new I June, every up important. time believe take new we customer there, we'll customers. to important and will on a base type have inventory it is point see bringing significant What or can be of we'll get need also to we to existing of customers be we time we things

seeing that's we already to need what So we're and see, it.

We Feb We X. another mentioned in start start, the we had February. new had

coming. month have we'll starting hospitals the and February, of in X it's So more

some hospitals, small, starts hospital will are multiple sizes users are some big, see. some can going X We'll some States. starts hopefully, of even lucky every medium, month, of we every United get and get that oxide nitric big. huge those of We might think the be to into the the of seeing -- very hospital I in having month, we're giant size break We'll club at customers. if see are

Matthew Kaplan

indication. That's just of it do surgery. approval Great. a expected supplement Okay. you And the terms to cardiac how Is this starting? progress? Great. helpful. expect in Is for you expect completed then than something longer is took to later this going? lot initial year? the How for be PMA label review the you Obviously, it and And

Steven Lisi

the But And way over. I on may -- could give don't of I assessment summer, it. the that think. the hard think sooner take we'll to to this going the could more the calendar But would before than things say one it's from want like date it's don't fair difficult that. I control be be be hear It's here. I to It fall. that could year a is pinpoint Matt, I FDA, back other. or it I people no it comment very some a end mean XXX days than to have

with aware, we're of from feedback short we're ways getting -- still FDA, little pass of hear a from first month bit the application. away It's little And FDA. we're a please days. think now, I going XXX several take don't because of beyond don't full as in when approval still put the that. So picture interactions pure my months it's May. part I a normally you're to of the FDA's right a would on would think getting you of our guess full it's bit

our we questions up. to mean, to part. Twitter We try at gearing we my So for that's can have in what prepare ready really that asked to do. generated and And wait. That's be . We can't guess team been trying to it. do feel my be We're sitting forward on discussing We're all and will are here confident the just a FDA. very strong. guess look I with data that think application.

So bit But hopefully, June have now, a just next little you. opinion. our update in more information it's I'll right for

Operator

the to I'd the like to There queue. closing Steve are back no remarks. further for questions call Lisi in hand

Steven Lisi

to We Thank tuning next you. Thanks, for with sharing appreciated. everyone, on progress the forward look you call. our in. Much

Operator

and today's participation. your Thank gentlemen, teleconference. this does Ladies for you conclude

day. lines wonderful your a have this at and time, disconnect may You

Beyond Air (XAIR) 12 Feb 242024 Q3 Earnings call transcript